Visalakshi Chandramouli
Managing Partner @ Tata Capital
Mumbai, India
Visalakshi Chandramouli is a Series A investor at Tata Capital in Mumbai focused on Sales and Retail. Visalakshi Chandramouli is the Managing Partner at Tata Capital Healthcare Fund. She attended Harvard Business School.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Visalakshi Chandramouli invests in
Stages Visalakshi Chandramouli invests in
Countries Visalakshi Chandramouli invests in
Investment Focus
Industry
- Sales 1 (33%)
- Retail 1 (33%)
- Health Care 1 (33%)
- Manufacturing 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Private Equity 1 (33%)
Country
- India 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Harsoria Healthcare
|
Harsoria Healthcare is a manufacturing company. Harsoria has installed its design and development section, the medical devices production sections, and the quality control and assurance section. their products range from iv cannula, three way stop cock, av fistula needle, extension tube, flow regulator, connectors, stoppers, infusion set, centralvenous catheter, transfusion set, safety iv cannula, and hemodialysis catheter. | $20M / Private Equity / Jan 09, 2025 | |
DeepTek
|
AI is a technology for the people. AI has the power and potential to radically transform healthcare. Deeptek will use in-house innovated "assisted and augmented" (AaA) imaging focused algorithmic tools designed by our experts and covering a wide arena of medical imaging like Radiographs, CT Scan and MRI. Deeptek's aim is to savehundreds of hours of valuable time of caregivers of the society, in our case radiologists! Saved time means additional reach of caregivers in treating more individuals in need of care and giving prompt results in time. Saved time on workflow management amounts to drastic saving in cost of healthcare by appropriate use of valuable time of experts like radiologists. DeepTek's vision will be to provide cutting edge solutions powered by deep learning algorithms which will bridge the wide gap in the imaging sector empowering radiologists with power which can potentially disrupt the dynamics of radiology workflow. Deeptek uses the latest technology to POWER ON the grid of medical radiology imaging. Be it the cloud powered GPU offerings which trigger the artificial neural networks, deep neural nets customized to the task at hand to advanced API, seamless interfaces and simple to use GUI, the radiologists will have it all on a platter. Deeptek's offerings will change your workstations and mobile devices to dependable analytical tools, which gives radiologists the confidence, reach and benefits of AI tech so that you could do more in less time. | $10M / Series A / Mar 07, 2022 | |
|
DeepTek
|
AI is a technology for the people. AI has the power and potential to radically transform healthcare. Deeptek will use in-house innovated "assisted and augmented" (AaA) imaging focused algorithmic tools designed by our experts and covering a wide arena of medical imaging like Radiographs, CT Scan and MRI. Deeptek's aim is to savehundreds of hours of valuable time of caregivers of the society, in our case radiologists! Saved time means additional reach of caregivers in treating more individuals in need of care and giving prompt results in time. Saved time on workflow management amounts to drastic saving in cost of healthcare by appropriate use of valuable time of experts like radiologists. DeepTek's vision will be to provide cutting edge solutions powered by deep learning algorithms which will bridge the wide gap in the imaging sector empowering radiologists with power which can potentially disrupt the dynamics of radiology workflow. Deeptek uses the latest technology to POWER ON the grid of medical radiology imaging. Be it the cloud powered GPU offerings which trigger the artificial neural networks, deep neural nets customized to the task at hand to advanced API, seamless interfaces and simple to use GUI, the radiologists will have it all on a platter. Deeptek's offerings will change your workstations and mobile devices to dependable analytical tools, which gives radiologists the confidence, reach and benefits of AI tech so that you could do more in less time. | $10M / Series A / Mar 07, 2022 |
Co-Investors
GHV Accelerator
2 deals together
Pentathlon Ventures
2 deals together
LNB group
1 deal together
Tata Capital
1 deal together
Tata Capital Healthcare Fund
1 deal together
About Tata Capital
Tata Capital is a non-banking financial company offering financial products and services to retail, corporate, and institutional customers. The company operates as a subsidiary of Tata Sons Limited, the principal holding company of the Tata Group. Tata Capital is committed to providing customer-centric financial solutions with a strong focus ontrust, transparency, and ethical practices.
Tata Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Akhil Awasthi
Managing Partner & Member Investment Committee
|
|||
Gautham Radhakrishnan
Partner
|
|||
|
Mohan Harshey
Partner
|
|||
Padmanabh Sinha
Managing Partner, Tata Opportunities Fund
|
|||
|
Visalakshi Chandramouli
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Visalakshi Chandramouli invest in?
Visalakshi Chandramouli invests primarily in Sales, Retail and Health Care startups, most often at Series A and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Visalakshi Chandramouli last invest?
The most recent investment recorded for Visalakshi Chandramouli closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
